Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages

Ruei-Ming Chen, Tyng-Guey Chen, Ta-Liang Chen, Li Ling Lin, Chia Ching Chang, Huai-Chia Chang, Chih-Hsiung Wu

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Sepsis is a serious and life-threatening syndrome that often occurs in intensive care unit (ICU) patients. During sepsis, inflammatory cytokines and nitric oxide (NO) can be overproduced, causing tissue and cell injury. Propofol is an intravenous agent used for sedation of ICU patients. Our previous study showed that propofol has immunosuppressive effects on macrophage functions. This study was designed to evaluate the anti-inflammatory and antioxidative effects of propofol on the biosyntheses of tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), IL-6, and NO in lipopolysaccharide (LPS)-activated macrophages. Exposure to a therapeutic concentration of propofol (50 μM), LPS (1 ng/mL), or a combination of these two drugs for 1, 6, and 24 h was not cytotoxic to the macrophages. ELISA revealed that LPS increased macrophage TNF-α, IL-1β, and IL-6 protein levels in a time-dependent manner, whereas propofol significantly reduced the levels of LPS-enhanced TNF-α, IL-1β, and IL-6 proteins. Data from RT-PCR showed that LPS induced TNF-α, IL-1β, and IL-6 mRNA, but propofol inhibited these effects. LPS also increased NO production and inducible nitric oxide synthase (iNOS) expression in macrophages. Exposure of macrophages to propofol significantly inhibited the LPS-induced NO biosynthesis. The present study shows that propofol, at a therapeutic concentration, has anti-inflammatory and antioxidative effects on the biosyntheses of TNF-α, IL-1β, IL-6, and NO in LPS-activated macro-phages and that the suppressive effects are exerted at the pretranslational level.

Original languageEnglish
Pages (from-to)262-271
Number of pages10
JournalAnnals of the New York Academy of Sciences
Volume1042
DOIs
Publication statusPublished - 2005

Fingerprint

Macrophages
Propofol
Lipopolysaccharides
Anti-Inflammatory Agents
Interleukin-1
Interleukin-6
Nitric Oxide
Tumor Necrosis Factor-alpha
Biosynthesis
Intensive care units
Intensive Care Units
Sepsis
Bacteriophages
Nitric Oxide Synthase Type II
Drug Combinations
Immunosuppressive Agents
Macros
Proteins
Enzyme-Linked Immunosorbent Assay
Tissue

Keywords

  • Anti-inflammation
  • Antioxidation
  • IL-1β
  • IL-6
  • Macrophages
  • Nitric oxide
  • Propofol
  • TNF-α

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. / Chen, Ruei-Ming; Chen, Tyng-Guey; Chen, Ta-Liang; Lin, Li Ling; Chang, Chia Ching; Chang, Huai-Chia; Wu, Chih-Hsiung.

In: Annals of the New York Academy of Sciences, Vol. 1042, 2005, p. 262-271.

Research output: Contribution to journalArticle

@article{6b19224f625a4e6ebad8dfa20752be7a,
title = "Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages",
abstract = "Sepsis is a serious and life-threatening syndrome that often occurs in intensive care unit (ICU) patients. During sepsis, inflammatory cytokines and nitric oxide (NO) can be overproduced, causing tissue and cell injury. Propofol is an intravenous agent used for sedation of ICU patients. Our previous study showed that propofol has immunosuppressive effects on macrophage functions. This study was designed to evaluate the anti-inflammatory and antioxidative effects of propofol on the biosyntheses of tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), IL-6, and NO in lipopolysaccharide (LPS)-activated macrophages. Exposure to a therapeutic concentration of propofol (50 μM), LPS (1 ng/mL), or a combination of these two drugs for 1, 6, and 24 h was not cytotoxic to the macrophages. ELISA revealed that LPS increased macrophage TNF-α, IL-1β, and IL-6 protein levels in a time-dependent manner, whereas propofol significantly reduced the levels of LPS-enhanced TNF-α, IL-1β, and IL-6 proteins. Data from RT-PCR showed that LPS induced TNF-α, IL-1β, and IL-6 mRNA, but propofol inhibited these effects. LPS also increased NO production and inducible nitric oxide synthase (iNOS) expression in macrophages. Exposure of macrophages to propofol significantly inhibited the LPS-induced NO biosynthesis. The present study shows that propofol, at a therapeutic concentration, has anti-inflammatory and antioxidative effects on the biosyntheses of TNF-α, IL-1β, IL-6, and NO in LPS-activated macro-phages and that the suppressive effects are exerted at the pretranslational level.",
keywords = "Anti-inflammation, Antioxidation, IL-1β, IL-6, Macrophages, Nitric oxide, Propofol, TNF-α",
author = "Ruei-Ming Chen and Tyng-Guey Chen and Ta-Liang Chen and Lin, {Li Ling} and Chang, {Chia Ching} and Huai-Chia Chang and Chih-Hsiung Wu",
year = "2005",
doi = "10.1196/annals.1338.030",
language = "English",
volume = "1042",
pages = "262--271",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages

AU - Chen, Ruei-Ming

AU - Chen, Tyng-Guey

AU - Chen, Ta-Liang

AU - Lin, Li Ling

AU - Chang, Chia Ching

AU - Chang, Huai-Chia

AU - Wu, Chih-Hsiung

PY - 2005

Y1 - 2005

N2 - Sepsis is a serious and life-threatening syndrome that often occurs in intensive care unit (ICU) patients. During sepsis, inflammatory cytokines and nitric oxide (NO) can be overproduced, causing tissue and cell injury. Propofol is an intravenous agent used for sedation of ICU patients. Our previous study showed that propofol has immunosuppressive effects on macrophage functions. This study was designed to evaluate the anti-inflammatory and antioxidative effects of propofol on the biosyntheses of tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), IL-6, and NO in lipopolysaccharide (LPS)-activated macrophages. Exposure to a therapeutic concentration of propofol (50 μM), LPS (1 ng/mL), or a combination of these two drugs for 1, 6, and 24 h was not cytotoxic to the macrophages. ELISA revealed that LPS increased macrophage TNF-α, IL-1β, and IL-6 protein levels in a time-dependent manner, whereas propofol significantly reduced the levels of LPS-enhanced TNF-α, IL-1β, and IL-6 proteins. Data from RT-PCR showed that LPS induced TNF-α, IL-1β, and IL-6 mRNA, but propofol inhibited these effects. LPS also increased NO production and inducible nitric oxide synthase (iNOS) expression in macrophages. Exposure of macrophages to propofol significantly inhibited the LPS-induced NO biosynthesis. The present study shows that propofol, at a therapeutic concentration, has anti-inflammatory and antioxidative effects on the biosyntheses of TNF-α, IL-1β, IL-6, and NO in LPS-activated macro-phages and that the suppressive effects are exerted at the pretranslational level.

AB - Sepsis is a serious and life-threatening syndrome that often occurs in intensive care unit (ICU) patients. During sepsis, inflammatory cytokines and nitric oxide (NO) can be overproduced, causing tissue and cell injury. Propofol is an intravenous agent used for sedation of ICU patients. Our previous study showed that propofol has immunosuppressive effects on macrophage functions. This study was designed to evaluate the anti-inflammatory and antioxidative effects of propofol on the biosyntheses of tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), IL-6, and NO in lipopolysaccharide (LPS)-activated macrophages. Exposure to a therapeutic concentration of propofol (50 μM), LPS (1 ng/mL), or a combination of these two drugs for 1, 6, and 24 h was not cytotoxic to the macrophages. ELISA revealed that LPS increased macrophage TNF-α, IL-1β, and IL-6 protein levels in a time-dependent manner, whereas propofol significantly reduced the levels of LPS-enhanced TNF-α, IL-1β, and IL-6 proteins. Data from RT-PCR showed that LPS induced TNF-α, IL-1β, and IL-6 mRNA, but propofol inhibited these effects. LPS also increased NO production and inducible nitric oxide synthase (iNOS) expression in macrophages. Exposure of macrophages to propofol significantly inhibited the LPS-induced NO biosynthesis. The present study shows that propofol, at a therapeutic concentration, has anti-inflammatory and antioxidative effects on the biosyntheses of TNF-α, IL-1β, IL-6, and NO in LPS-activated macro-phages and that the suppressive effects are exerted at the pretranslational level.

KW - Anti-inflammation

KW - Antioxidation

KW - IL-1β

KW - IL-6

KW - Macrophages

KW - Nitric oxide

KW - Propofol

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=22044447263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22044447263&partnerID=8YFLogxK

U2 - 10.1196/annals.1338.030

DO - 10.1196/annals.1338.030

M3 - Article

C2 - 15965071

AN - SCOPUS:22044447263

VL - 1042

SP - 262

EP - 271

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -